Abstract
Unregulated expression of wild-type BRCA1 (wtBRCA1) confers an altered phenotype in cultured human prostate cancer cells, characterized by chemosensitivity, susceptibility to apoptosis, decreased DNA repair activity, and alterations of key cell regulatory proteins. We now report that the expression of truncated or mutant full-length BRCA1 genes can abrogate certain phenotypic characteristics and/or confer the opposite phenotype to the wild-type BRCA1 gene. In particular, several carboxyl-terminal truncated BRCA1 proteins conferred chemoresistance, decreased susceptibility to apoptosis, and decreased ability to suppress in vivo tumor growth. These truncated BRCA1 proteins also blocked the ability of ectopically expressed wtBRCA1 to induce chemosensitivity and to inhibit estrogen receptor transcriptional activity. Studies using epitope-tagged truncated proteins confirmed their expression, nuclear localization, and functionality. On the other hand, in cells with no endogenous wild-type BRCA1 (HCC1937 human breast cancer cells), the wtBRCA1 gene enhanced cellular DNA repair activity and rendered the cells resistant to DNA damage; while truncated BRCA1 proteins blocked the wtBRCA1-induced chemoresistance. Our findings suggest that truncated BRCA1 proteins can inhibit the function of wild-type BRCA1. They raise the possibility that some inherited BRCA1 mutations may actively promote oncogenesis by blocking the function of the remaining wild-type BRCA1 allele, although this hypothesis remains to be proved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT . 1999 J. Biol. Chem. 274: 18808–18812
Alley MC, Scudieco DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR . 1988 Cancer Res. 48: 589–601
Andres JL, Fan S, Turkel GJ, Wang J-A, Twu N-F, Yuan R-Q, Lamszus K, Golberg ID, Rosen EM . 1998 Oncogene 16: 2229–2241
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Besho M, Jensen RA, Liu ET . 1999 Proc. Natl. Acad Sci. USA 96: 11866–11871
Bertrand R, Pommier Y . 1995 In: Studzinski GP (ed). Cell Growth and Apoptosis Oxford University Press pp. 97–117
Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhatter R . 2000 Cell 102: 257–265
Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH . 1996a J. Biol. Chem. 271: 32863–32868
Chen Y, Farmer AA, Chen C-F, Jones DC, Chen P-L, Lee W-H . 1996b Cancer Res. 56: 3168–3172
Cortez D, Wang Y, Qin J, Elledge SJ . 1999 Science 286: 1162–1166
Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ . 1993 Nat. Genet. 4: 42–46
Fan S, Wang J-A, Yuan R-Q, Ma YX, Meng Q, Goldberg ID, Rosen EM . 1998 Oncogene 16: 3069–3083
Fan S, Wang J-A, Meng Q, Yuan R-Q, Ma YX, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, Rosen EM . 1999a Science 284: 1354–1356
Fan S, Wang J-A, Yuan R-Q, Goldberg ID, Rosen EM . 1999b Prostate 40: 37–49
Fan S, Wang J-A, Ma YX, Wang C, Yuan R-Q, Meng Q, Erdos MR, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM . 2001a Oncogene 20: 77–87
Fan S, Yuan R-Q, Ma YX, Xiong J, Meng Q, Erdos M, Goldberg ID, Rosen EM . 2001b Oncogene 20: 4827–4841
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE . 1994 Lancet 343: 692–695
Freundlieb S, Baron U, Bonin AL, Gossen M, Bujard H . 1997 Methods Enzymol. 283: 159–173
Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC . 1994 Nat. Genet. 8: 399–404
Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, Fan S . 2001 FEBS Lett. 488: 179–184
Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, Rensburg EJ, Dunning, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ . 1995 Nat. Genet. 11: 428–433
Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA . 1998 Science 281: 1009–1012
Hakem R, de la Pomba JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW . 1996 Cell 85: 1009–1023
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Mahenwaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586
Henttu PMA, Kalkhoven E, Parker MG . 1998 Mol. Cell. Biol. 17: 1832–1939
Herrmann M, Lorenz H-M, Voll R, Grunke M, Woith W, Kalden JR . 1994 Nucl. Acids Res. 22: 5506–5507
Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C, Jensen RA . 1996 Nat. Genet. 12: 298–302
Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJ, Strauss M, Bartek J . 1994 Oncogene 9: 2159–2167
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow P, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH . 1994 Science 266: 66–71
Monteiro AN, August A, Hanafusa H . 1996 Proc. Natl. Acad. Sci. USA 93: 13595–13599
Moynahan ME, Chiu JW, Koller BH, Jasin M . 1999 Mol. Cell 4: 511–518
Ouichi T, Monteiro AN, August A, Aarsonson SA, Hanafusa H . 1998 Proc. Natl. Acad. Sci. USA 95: 2302–2306
Rajan JV, Wang M, Marquis ST, Chodosh LA . 1997 Proc. Natl. Acad. Sci. USA 93: 3078–3083
Rao VN, Shao N, Ahmad M, Reddy ES . 1996 Oncogene 12: 523–528
Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S . 1991 Proc. Natl. Acad. Sci. USA 88: 10657–10661
Sarkar FH, Sakr W, Li YW, Macoska J, Ball DE, Crissman JD . 1992 Prostate 21: 145–152
Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD . 1997a Proc. Natl. Acad. Sci. USA 94: 5605–5610
Scully R, Chen J, Plug A, Xiao P, Weaver D, Feunteau J, Ashley T, Livingston D . 1997b Cell 88: 265–275
Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston D . 1997c Cell 90: 425–435
Shao N, Chai YL, Shyam E, Reddy P, Rao VM . 1996 Oncogene 13: 1–7
Shaulian E, Zauberman A, Ginsberg D, Oren M . 1992 Mol. Cell Biol. 12: 5581–5592
Somasundaram K, Zhang H, Zeng Y-X, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190
Streuwing JP, Hartge P, Wacholder S, Baker SM, Berlin M. McAdams M, Timmerman MM, Brody LC, Tucker MA . 1997 New Engl, J, Med. 336: 1401–1408
Taylor J, Lamboura M, Pace PE, A′hern RP, Desai AJ, Shousha S, Coombes RC, Ali S . 1998 Int. J. Cancer 79: 334–342
Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT . 1995 Nat. Genet. 9: 444–450
Tirkkonen M, Johannson O, Agnarsson BA, Olsson H, Ingvarsson S, Karbu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP . 1997 Cancer Res. 57: 1222–1227
Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Weisman RW, Berchuck A, Inglehart JD, Futreal PA, Marks JR . 1996 Cell Growth Differ. 7: 711–715
Wang H, Shao N, Ding OM, Qui J-Q, Reddy ESP, Rao VN . 1997 Oncogene 15: 143–157
Wang P, Zhang H, Kajino K, Greene MI . 1999 Oncogene 17: 1939–1948
Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL . 1995 Mol. Endocrinol. 9: 1804–1813
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Zu XL, Yang MC, Hwang LW, Bowcock AM, Baer R . 1996 Nat. Genet. 14: 430–440
Yarden RI, Brody LC . 1999 Proc. Natl. Acad. Sci. USA 96: 4983–4988
Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392
Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS . 1998 Oncogene 16: 1713–1721
Acknowledgements
This research was supported, in part, by research grants from the USPHS (R01-ES09169, R01-CA-80000, and R01-CA82599), the Susan G Komen Breast Cancer Foundation (BASIC-003255), and the US Army Breast Cancer Research Program (DAMD17-99-1-9254).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, S., Yuan, Rq., Ma, Y. et al. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20, 8215–8235 (2001). https://doi.org/10.1038/sj.onc.1205033
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205033
Keywords
This article is cited by
-
MTAP-ANRIL gene fusion promotes melanoma epithelial-mesenchymal transition-like process by activating the JNK and p38 signaling pathways
Scientific Reports (2023)
-
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Molecular Cancer (2022)
-
Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy
Journal of Experimental & Clinical Cancer Research (2021)
-
Nonsense-mediated RNA decay and its bipolar function in cancer
Molecular Cancer (2021)
-
DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers
Breast Cancer Research and Treatment (2015)